18 results
DFAN14A
KDNY
Chinook Therapeutics Inc
12 Jun 23
Additional proxy materials by non-management
9:41am
in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research
425
KDNY
Chinook Therapeutics Inc
10 Jun 20
Business combination disclosure
4:16pm
to apply our guiding R&D principles to advance our preclinical pipeline, and will evaluate partnering opportunities in several areas. Ultimately, our
425
KDNY
Chinook Therapeutics Inc
2 Jun 20
Business combination disclosure
9:52pm
. We will also continue to apply our guiding R&D principles to advance our preclinical pipeline, and will evaluate partnering opportunities in several
425
z2r1u0 j5v268gtn6zrh
2 Jun 20
Business combination disclosure
5:24pm
425
chm xb00umjc
2 Jun 20
Business combination disclosure
5:23pm
425
7fh822nnu0x06mr93
2 Jun 20
Business combination disclosure
5:22pm
8-K
EX-99.2
m34zgulj6 z5w7g
2 Jun 20
Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement
9:19am
425
EX-99.2
zfx k0wab0cgjactheau
2 Jun 20
Business combination disclosure
9:17am
8-K
EX-99.1
dt4qafgoztq2y
13 Jan 20
Other Events
6:09am
10-K
z6gcurbig0i
8 Mar 16
Annual report
12:00am
- Prev
- 1
- Next